Product NDC: | 49401-103 |
Proprietary Name: | Raxibacumab |
Non Proprietary Name: | raxibacumab |
Active Ingredient(s): | 50 mg/mL & nbsp; raxibacumab |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 49401-103 |
Labeler Name: | Human Genome Sciences, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | BLA125349 |
Marketing Category: | BLA |
Start Marketing Date: | 20121214 |
Package NDC: | 49401-103-01 |
Package Description: | 1 VIAL, SINGLE-USE in 1 CARTON (49401-103-01) > 34 mL in 1 VIAL, SINGLE-USE |
NDC Code | 49401-103-01 |
Proprietary Name | Raxibacumab |
Package Description | 1 VIAL, SINGLE-USE in 1 CARTON (49401-103-01) > 34 mL in 1 VIAL, SINGLE-USE |
Product NDC | 49401-103 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | raxibacumab |
Dosage Form Name | INJECTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20121214 |
Marketing Category Name | BLA |
Labeler Name | Human Genome Sciences, Inc. |
Substance Name | RAXIBACUMAB |
Strength Number | 50 |
Strength Unit | mg/mL |
Pharmaceutical Classes |